Skip to main content
Premium Trial:

Request an Annual Quote

NIEHS to Fund Studies of Toxic Exposure Impacts on Gene Expression, Chromatin

NEW YORK (GenomeWeb News) – The National Institute of Environmental Health Sciences plans to provide up to $3 million next year to fund research into how exposure to toxic chemicals in the environment affects gene expression.

In a new funding announcement, NIEHS said that it plans to fund grants with up to $400,000 next year that seek to define how environmental exposures affect proteins and other elements that govern gene expression patterns and chromatin states.

Exposure to toxicants that cause changes in gene expression and DNA methylation profiles can lead to diseases such as autoimmune and neurodevelopmental disorders and cancer. NIEHS has over the past decade been supporting projects that focus on exposures to toxicants such as arsenic, tobacco smoke, airborne particulates, and others.

The institute said it has already made "a significant investment" in research to identify epigenetic signatures of exposure, and now it wants to support studies that home in on how these exposures perturb proteins and processes that occur upstream of DNA methylation and other epigenetic marks.

The goal for this program is to begin to move beyond descriptive and correlative studies to understand the mechanisms involved in environmental exposure and gene expression.

Projects funded under this program may include, but are not limited to, research into chromatin accessibility and nucleosome positioning; the role of exposures in influencing the distribution, turnover, and positioning of nucleosomes; chromatin remodeling; the effects of exposures on non-coding RNA DNA/nucleosome binding; and studies that examine mechanisms involved in exposure related to the disruption of normal cis-regulatory functions.

Also under this funding program, the National Institute on Drug Abuse plans to fund one award of $400,000 for research that investigates the impact of drugs of abuse on chromatin. These projects will use high-throughput assays that can reveal changes in chromatin looping, 3D-chromatin structure, or interactions between non-coding RNAs with chromatin to study impacts of drugs such as nicotine, stimulants, opioids, abused prescription medicines, psychedelics, and others.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.